| Similar Articles |
|---|
 |
Bio-IT World
August 15, 2005 |
News Blast Computational drug discovery solutions provider Eidogen-Sertanty launched a chemist-friendly design service... Thomson Scientific providing an XML gateway to its collection of publications... Inpharmatica launched a modular protein annotation system... etc.   |
Bio-IT World
Dec 2006/Jan 2007 |
Briefs Screening Sold... Belgian Acquisition... Edc Master... Astellas Licenses... etc. |
Bio-IT World
January 13, 2003
Michael Gross |
Profiting from the Proteome Inpharmatica sells data products, but it also wants to discover drugs. |
Bio-IT World
September 2006
Kevin Davies |
Pfizer's Global Survey of Pharmacological Space The pharma blends knowledge, computational chemistry and research informatics to build a unified database. Gathering all the data in one place offered greater control for indexing and data retrieval and management, enabling Pfizer scientists to perform global mapping. |
Bio-IT World
December 10, 2002
Malorye Branca |
The Trouble with Pharmaceutical Innovation There's a lot of one kind, but not enough of another in pharma land. Too many new technologies and too few new drugs -- that sums up the state of pharmaceutical R&D. |
Bio-IT World
April 15, 2003
Mark D. Uehling |
Target Elimination Industry and FDA scientists turn to databases, applications software, and laboratory chips to move the safest, most effective molecules into clinical trials. |
The Motley Fool
November 15, 2006
Alyce Lomax |
A Very Complicated Discovery Complexity rules in Discovery Holding's third-quarter results. Investors, take note. |
